Sold as Tensilon, Tensilon Preservative Free. Every FDA application for this active ingredient: 1 branded and 5 generic.
As of Nov 15, 2026, FDA lists 6 applications for Edrophonium Chloride (sold as Tensilon, Tensilon Preservative Free), first approved May 3, 1951, with 0 new uses approved and 0 published complete response letters.
| May 3, 1951 | Tensilon, Tensilon Preservative FreeNDA 7959 · New molecular entity | Pai Holdings Pharm | 7 | Discontinued |
| Aug 6, 1985 | EnlonANDA 88873 | Pharmobedient | 13 | Discontinued |
| May 13, 1988 | ReversolANDA 89624 | Organon USA Inc | 7 | Discontinued |
| Feb 24, 1998 | Edrophonium ChlorideANDA 40131 | Hospira | 1 | Discontinued |
| — | Edrophonium Chloride Preservative FreeANDA 40043 | Watson Labs | 0 | Discontinued |
| — | Edrophonium ChlorideANDA 40044 | Watson Labs | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
